1 tracked superinvestor hold TREVI THERAPEUTICS INC (TRVI), worth $29M combined, led by Andreas Halvorsen. Smart money is trimming TRVI as of the latest 13F filings.
Current price
$17.26
+138.7%
1Y
Trevi Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the advancement and commercialization of Haduvio, a potential treatment for debilitating neurologically mediated conditions. This orally administered, extended-release formulation of nalbuphine is currently undergoing Phase IIb/III clinical trials for chronic pruritus (severe itching) and persistent cough…
Market cap
$2.0B
P/E
-43.34
Div yield
0.0%
Revenue YoY
0.0%
Analyst target
$30
Snapshot for context. For deep analysis use a stock screener — this page is about who owns it.
Superinvestors holding
1
tracked 13F / N-PORT funds
Combined value
$29M
disclosed long exposure
Tier-1 conviction
1
concentrated holders
Net this quarter
-1
0 buying · 1 selling
Smart money is net reducing TRVI: 1 funds trimmed versus 0 adding.
TREVI THERAPEUTICS INC (TRVI) is held by 1 tracked funds worth $29M combined, 1 of them concentrated Tier-1 managers whose positions carry real conviction.
The largest position belongs to Andreas Halvorsen at 0.1% of their book — no single tracked manager treats it as an outsized, top-weighted bet.
No tracked fund opened a new position this quarter; 0 added and 1 trimmed, a net reduction.
| Investor | Move | % of their portfolio | Position value |
|---|---|---|---|
| Trimmed | 0.1% | $29M |
Tier badge = signal quality: 1 concentrated conviction · 2 quant/multi (context) · 3 retail & diversified. Only Tier 1 holdings feed the consensus signal.
1 insider filed SEC Form 144 for $627K of proposed sales in the last 90 days. A 144 is filed before the trade — see who else is selling.
| Insider | Role | Shares | Value | Filed |
|---|---|---|---|---|
| Michael Heffernan | Director | 39,473 | $627K | 2026-09-15 |
Which superinvestors own TRVI?
1 tracked funds hold TREVI THERAPEUTICS INC (TRVI), the largest being Andreas Halvorsen (Viking Global Investors) at 0.1% of its 13F portfolio. 1 of them are concentrated Tier-1 conviction managers.
Is smart money buying or selling TRVI?
In the most recent 13F quarter, 0 tracked funds added or opened TRVI and 1 trimmed it.
How much TRVI do tracked funds hold?
Combined disclosed long exposure to TRVI across tracked superinvestors is $29M as of the Jun 2026 filings.
One email when a tracked manager opens, adds to or files to sell a position — from Form 4, 13D and Form 144, not the 45-day-old 13F.
Holdings aggregated from the latest SEC 13F & N-PORT filings via FMP · Jun 2026 quarter. Long equity positions only, reported with up to a 45-day delay — for activity between filings see real-time moves. Not financial advice.